Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Modified charlson comorbidity index in predicting early mortality after liver transplantation

M Wasilewicz, J Raszeja-Wyszomirska, M Wójcicki, P Milkiewicz

Ann Transplant 2009; 14(1): 39-40 :: ID: 880341

Abstract

Background: Charlson Co morbidity Index-Orthotopic LT (CCI-OLT) is a modified clinical score recently found to be useful in the assessment of a long term survival after liver transplantation (LTx) (Volk et al. Liver Transplantation 2007). It includes 9 most important associated conditions selected in multivariate analysis on a large cohort of transplanted patients. Its role in predicting early mortality after LTx has not yet been investigated. Aim: Evaluation of CCI-OLT as a potential predictor of one-month mortality after LTx.
Material/Methods: A group of 169 consecutive patients (103 males and 67 females, median age in both groups 51 years) who received their elective LTx at our centre was analysed. Patients transplanted for fulminant hepatic failure were excluded from the analysis. Viral (39%) and alcohol induced (23%) cirrhosis were most common indications for LTx. CCI-OLT index was assessed in all patients. Statistical analysis was performed with StatView Program.
Results: 146 (86%) subjects survived and 23 (14%) died within 1 month after
LTx. Fifty one (30%) patients suffered from at least 1 co-morbidity included in CCI-OLT index, a number significantly lower than in population studied by Volk et al. Direct comparison of the groups of survivors and non-survivors showed no significant difference in terms of the total frequency of co-morbidities (30.1% vs. 30.4%, p>0.99), their number and type. The most common associated condition in both groups was diabetes mellitus.
Conclusions: Contrary to the long term survival, CCI-OLT does not seem to have a role as a predictor of early (one-month) mortality after LTx.

Keywords: Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358